Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12011439
APP PUB NO 20230097128A1
SERIAL NO

17820179

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure is drawn to the combination therapy of a C-C Chemokine Receptor 4 (CCR4) antagonist and one or more immune checkpoint inhibitors in the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHEMOCENTRYX INC850 MAUDE AVENUE MOUNTAIN VIEW CA 94043

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Shijie Los Altos, US 28 113
Mali, Venkat Reddy Cupertino, US 56 249
Singh, Rajinder Belmont, US 480 10970
Yang, Ju Palo Alto, US 72 605
Zhang, Penglie Foster City, US 164 1806

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 18, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 18, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 18, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00